文献リスト

1) Starzl TE, Marchioro TL, Vonkaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963; 117: 659-76

2) Starzl TE, Groth CG, Brettschneider L, et al. Orthotopic homotransplantation of the human liver. Ann Surg. 1968; 168: 392-415

3) Calne RY, Rolles K, White DJ, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979; 2: 1033-6

4) Starzl TE, Klintmalm GB, Porter KA, et al. Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med. 1981; 305: 266-9

5) Starzl TE, Todo S, Fung J, et al. FK 506 for liver, kidney, and pancreas transplantation. Lancet. 1989; 2: 1000-4

6) Kalayoglu M, Sollinger HW, Stratta RJ, et al. Extended preservation of the liver for clinical transplantation. Lancet. 1988; 1: 617-9

7) Todo S, Nery J, Yanaga K, et al. Extended preservation of human liver grafts with UW solution. JAMA. 1989; 261: 711-4

8) O'Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. 2008; 134: 1764-76

9) Brown R Jr, Emond JC. Managing access to liver transplantation: implications for gastroenterology practice. Gastroenterology. 2007; 132: 1152-63

10) Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005; 241: 905-16

11) Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4, 000 consecutive patients at a single center. Ann Surg. 2000; 232: 490-500

12) Jain A, Mazariegos G, Kashyap R, et al. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002; 73: 941-7

13) Terrault NA, Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl. 2006; 12: 1192-204

14) Mukherjee S, Sorrell MF. Controversies in liver transplantation for hepatitis C. Gastroenterology. 2008; 134: 1777-88

15) Chen CL, Wang KL, Lee MC, et al. Liver transplantation for Wilson's disease−Report of the first successful liver transplant in Taiwan. Jpn J Transplant. 1987; 22: 178

16) Akabayashi A. Japan's parliament passes brain-death law. Lancet. 1997; 349: 1895

17) Kawasaki S, Hashikura Y, Ikegami T, et al. First case of cadaveric liver transplantation in Japan. J Hepatobiliary Pancreat Surg. 1999; 6: 387-90

18) Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet. 1989; 334: 497

19) Strong RW, Lynch SV, Ong TH, et al. Successful liver transplantation from a living donor to her son. N Engl J Med. 1990; 322: 1505-07

20) Nagasue N, Kohno H, Matsuo S, et al. Segmental (partial) liver trans-plantation from a living donor. Transplantation Proc. 1992; 24: 1958-9

21) Hashikura Y, Makuuchi M, Kawasaki S, et al. Successful living related partial liver transplantation to an adult patient. Lancet. 1994; 343: 1233-4

22) 日本肝移植研究会. 肝移植症例登録報告(第二報). 移植. 2008; 43: 45-55

23) Umeshita K, Fujiwara K, Kiyosawa K, et al. Operative morbidity of living liver donors in Japan. Lancet. 2003; 362: 687

24) Akabayashi A, Slingsby BT, Fujita M. The first donor death after living-related liver transplantation in Japan. Transplantation. 2004; 77: 634

25) http://jlts.umin.ac.jp/donor_survey_full.pdf

26) http://www.optn.org/

27) Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31: 864-71

28) Freeman RB Jr, Wiesner RH, Harper A, et al. UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002; 8: 851-8

29) Freeman RB Jr. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology. 2008; 47: 1052-7

30) http://www.eurotransplant.nl/

31) http://www.scandiatransplant.org/

32) http://www.uktransplant.org.uk/ukt/

33) http://www.agence-biomedecine.fr/fr/index.aspx

34) http://www.ont.es/

35) Matesanz R, Miranda B. A decade of continuous improvement in cadaveric organ donation: the Spanish model. J Nephrol. 2002; 15: 22-8

36) Sanchez-Bueno F, Cuende N, Matesanz R, et al. Emergency organ transplantation in Spain: liver emergency and outcomes. Transplant Proc. 2005; 37: 3878-80

37) Chang GJ, Mahanty HD, Ascher NL, et al. Expanding the donor pool: can the Spanish model work in the United States？ Am J Transplant. 2003; 3: 1259-63

38) Mizraji R, Alvarez I, Palacios RI, et al. Punta Cana Group of Latin American Transplant Coordinators. Organ donation in Latin America. Transplant Proc. 2007; 39: 333-5

39) Matesanz R. Factors influencing the adaptation of the Spanish model of organ donation. Transpl Int. 2003; 16: 736-41

40) Freeman RB Jr, Steffick DE, Guidinger MK, et al. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant. 2008; 4: 958-76

41) Brown RS Jr. Live donors in liver transplantation. Gastroenterology. 2008; 134: 1802-13

42) Rakela J, Fung JJ. Liver transplantation in China. Liver Transpl. 2007; 13: 182

43) Chelala C. Prospect of discussions on prisoners' organs for sale in China. Lancet. 1997; 350: 1307

44) Diflo T. Use of organs from executed Chinese prisoners. Lancet. 2004; 364 Suppl 1: s30-1

45) Huang J. Ethical and legislative perspectives on liver transplantation in the People's Republic of China. Liver Transpl. 2007; 13: 193-6

46) http://www.cltr.org/en/

47) www.konos.go.kr/

48) Steering Committee of the Istanbul Summit. Organ trafficking and transplant tourism and commercialism: the Declaration of Istanbul. Lancet. 2008; 372: 5-6

49) http://www.prnewswire.com/mnr/transplantationsociety/33914/docs/33914-Declaration_of_Istanbul-Lancet.pdf

50) de Villa VH, Lo CM, Chen CL. Ethics and rationale of living-donor liver transplantation in Asia. Transplantation. 2003; 75(3 Suppl): S2-5

51) http://www.jotnw.or.jp/index.html

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp